Ron Cohen
2016
In 2016, Ron Cohen earned a total compensation of $3.4M as President and Chief Executive Officer at Acorda Therapeutics, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $562,380 |
|---|---|
| Option Awards | $1,043,884 |
| Salary | $772,500 |
| Stock Awards | $1,046,501 |
| Other | $7,950 |
| Total | $3,433,215 |
Cohen received $1M in stock awards, accounting for 30% of the total pay in 2016.
Cohen also received $562.4K in non-equity incentive plan, $1M in option awards, $772.5K in salary and $8K in other compensation.
Rankings
In 2016, Ron Cohen's compensation ranked 2,705th out of 14,075 executives tracked by ExecPay. In other words, Cohen earned more than 80.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,705 out of 14,075 | 81st |
Division Manufacturing | 930 out of 5,489 | 83rd |
Major group Chemicals And Allied Products | 272 out of 1,895 | 86th |
Industry group Drugs | 198 out of 1,538 | 87th |
Industry Biological Products, Except Diagnostic Substances | 44 out of 279 | 84th |
Source: SEC filing on April 21, 2017.
Cohen's colleagues
We found five more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2016.
2016
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2016
Jane Wasman
Acorda Therapeutics
General Counsel
2016
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2016
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2016
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019